These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 2588264

  • 1. A comparison of the effects of tetraplatin and cisplatin on renal function and gentamicin pharmacology in rats.
    Engineer MS, Brown NS, Ho DH, Newman RA, Bulger RE.
    Toxicology; 1989 Dec 01; 59(2):151-62. PubMed ID: 2588264
    [Abstract] [Full Text] [Related]

  • 2. A comparison of the effects of cisplatin and N-methyliminodiacetato-(1,2-diaminocyclohexane)-platinum(II) on renal function and gentamicin excretion in rats.
    Engineer MS, Ho DH, Khokhar AR, Newman RA, Bulger RE.
    Toxicology; 1987 Dec 14; 47(3):307-15. PubMed ID: 3424386
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue.
    Rahman A, Roh JK, Wolpert-DeFilippes MK, Goldin A, Venditti JM, Woolley PV.
    Cancer Res; 1988 Apr 01; 48(7):1745-52. PubMed ID: 3162402
    [Abstract] [Full Text] [Related]

  • 4. Comparative toxicity and renal distribution of the platinum analogs tetraplatin, CHIP, and cisplatin at equimolar doses in the Fischer 344 rat.
    Smith JH, Smith MA, Litterst CL, Copley MP, Uozumi J, Boyd MR.
    Fundam Appl Toxicol; 1988 Jan 01; 10(1):45-61. PubMed ID: 3350229
    [Abstract] [Full Text] [Related]

  • 5. In vivo biochemical indices of nephrotoxicity of platinum analogs tetraplatin, CHIP, and cisplatin in the Fischer 344 rat.
    Smith MA, Smith JH, Litterst CL, Copley MP, Uozumi J, Boyd MR.
    Fundam Appl Toxicol; 1988 Jan 01; 10(1):62-72. PubMed ID: 3350230
    [Abstract] [Full Text] [Related]

  • 6. A comparison in rodents of renal and intestinal toxicity of cisplatin and a new water-soluble antitumor platinum complex: N-methyl-iminodiacetato-diaminocyclohexane platinum (II).
    Newman RA, Khokhar AR, Sunderland BA, Travis EL, Bulger RE.
    Toxicol Appl Pharmacol; 1986 Jul 01; 84(3):454-63. PubMed ID: 3726868
    [Abstract] [Full Text] [Related]

  • 7. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
    de Jong WH, Steerenberg PA, Vos JG, Bulten EJ, Verbeek F, Kruizinga W, Ruitenberg EJ.
    Cancer Res; 1983 Oct 01; 43(10):4927-34. PubMed ID: 6683993
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II).
    Wilkoff LJ, Dulmadge EA, Trader MW, Harrison SD, Griswold DP.
    Cancer Chemother Pharmacol; 1987 Oct 01; 20(2):96-100. PubMed ID: 3664938
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.
    Dedon PC, Borch RF.
    Biochem Pharmacol; 1987 Jun 15; 36(12):1955-64. PubMed ID: 2954556
    [Abstract] [Full Text] [Related]

  • 10. The interactions of cis-diamminedichloroplatinum with metallothionein and glutathione in rat liver and kidney.
    Suzuki CA, Cherian MG.
    Toxicology; 1990 Nov 15; 64(2):113-27. PubMed ID: 1977210
    [Abstract] [Full Text] [Related]

  • 11. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
    Bodenner DL, Dedon PC, Keng PC, Katz JC, Borch RF.
    Cancer Res; 1986 Jun 15; 46(6):2751-5. PubMed ID: 3009000
    [Abstract] [Full Text] [Related]

  • 12. Para-aminobenzoic acid suppression of cis-diamminedichloroplatinum(II) nephrotoxicity.
    Esposito M, Vannozzi MO, Viale M, Fulco RA, Collecchi P, Merlo F, De Cian F, Zicca A, Cadoni A, Poirier MC.
    Carcinogenesis; 1993 Dec 15; 14(12):2595-9. PubMed ID: 8269632
    [Abstract] [Full Text] [Related]

  • 13. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
    Siddik ZH, Thai G, Yoshida M, Zhang YP, Khokhar AR.
    Anticancer Drug Des; 1994 Dec 15; 9(6):495-509. PubMed ID: 7880375
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of cisplatin-induced nephrotoxicity on gentamicin pharmacokinetics in rats.
    Engineer MS, Bodey GP, Newman RA, Ho DH.
    Drug Metab Dispos; 1987 Dec 15; 15(3):329-34. PubMed ID: 2886307
    [Abstract] [Full Text] [Related]

  • 16. Glutathione-mediated modulation of tetraplatin activity against sensitive and resistant tumor cells.
    Kido Y, Khokhar AR, Siddik ZH.
    Biochem Pharmacol; 1994 Apr 29; 47(9):1635-42. PubMed ID: 8185678
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.